DOI:
10.1055/s-00000007
Aktuelle Urologie
Ausgabe 02 ·
Volume 49 ·
April 2018
DOI: 10.1055/s-008-39442
eFirst
Ausgabe
Meistgelesen
Erratum
e92
Kaftan, B. T.;
Wiedemann, A.:
Editorial
105
Referiert und kommentiert
114
116
118
120
122
125
König, F.;
Johannsen, M.;
Klier, J.;
Schönfelder, R.;
Eichenauer, R.;
Rexer, H.;
Gschwend, J.;
Suttmann, H.;
Doehn, C.:
Tipps und Tricks
127
Kaftan, B. T.;
Wiedemann, A.:
Klinik und Praxis
132
Recht in der Praxis
137
Originalarbeit
142
Miller, Kurt;
Gschwend, Jürgen E.;
Merseburger, Axel;
Retz, Margitta;
Stenzl, Arnulf:
Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma
164
Lebentrau, Steffen;
May, Matthias;
Ziegler, Heiko;
Werthemann, Peter;
Enzmann, Thomas;
Schostak, Martin;
Porsch, Markus;
BUSTER-Studiengruppe:
The recommendations of the S2k guideline for the diagnosis, therapy and metaphylaxis of urolithiasis provide a safe course of action for ureterorenoscopic stone treatment – results of the BUSTER study
Übersicht
157
Christoph, Frank;
König, Frank;
Lebentrau, Stefan;
Blaschke, Simon;
Liehr, Uwe-Bernd;
Schostak, Martin:
Thermochemotherapy with Mitomycin C: an update on alternative treatment strategies in non-muscleinvasive bladder cancer
171
Compérat, Eva;
Eymerit, Caroline;
Moroch, Julien;
Varinot, Justin:
The role of biomarkers in the diagnosis, prognosis and therapy of patients with immuno-oncological treatments of genito-urinary carcinomas
178
Bedke, Jens;
Todenhöfer, Tilman;
Stenzl, Arnulf:
Immune checkpoint inhibition in metastatic urothelial carcinoma
187
Grimm, Marc-Oliver;
Foller, Susan:
Immunotherapy for renal cell carcinoma – current status
OP-Techniken
192
